Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Review
a r t i c l e
i n f o
Article history:
Received 21 June 2011
Accepted 23 November 2011
Available online 13 December 2011
Keywords:
Nanodiagnostics
Bacterial
Dendrimer
Quantum dots
Liposomes
Virus
a b s t r a c t
In recent times, infectious diseases are posing to be a major healthcare issue. The contagious nature of these
diseases makes it imperative to develop logical solutions for early diagnosis and containment of these diseases.
Traditional techniques suffer from limitations, including laborious sample preparation, bulky instrumentation
and slow data readout. In view of the urgency for sensitive, specic, robust and rapid diagnostics, numerous advancements have been made in the area of diagnostics. Broadly, most of these innovative approaches, have utilized the unique properties of nanomaterials in order to achieve detection of infectious agents, even in complex
media like blood, urine. Additionally, researchers have also leveraged the advantages of nanomaterials by coupling with novel methods, such as surface plasmon spectroscopy, amperometry and magnetic relaxation. Thus,
this review intends to provide an overview on nanotechnology-based in-vitro diagnostics encompassing the useful role of both bioreceptors and transducers in the diagnosis of infectious diseases in diverse settings throughout
the globe, preventing epidemics and safeguarding human and economic wellness.
2011 Elsevier B.V. All rights reserved.
Contents
1.
2.
3.
4.
General introduction . . . . . . . . . . . . . . . . .
1.1.
Traditional diagnostic techniques . . . . . . . .
1.1.1.
Isolation, growth and microscopy . . .
1.1.2.
Immunology-based methods . . . . . .
1.1.3.
Polymerase chain reaction (PCR) . . . .
1.1.4.
Miscellaneous techniques . . . . . . .
Potential of nanotechnology . . . . . . . . . . . . .
Nanotechnology based bioreceptors . . . . . . . . . .
3.1.
Liposomes . . . . . . . . . . . . . . . . . .
3.2.
Carbon nanotubes . . . . . . . . . . . . . . .
3.3.
Dendrimers . . . . . . . . . . . . . . . . . .
3.4.
Gold nanoparticles (AuNPs) . . . . . . . . . .
3.5.
Conducting polymeric nanoparticles . . . . . .
3.6.
Polystyrene nanoparticles . . . . . . . . . . .
3.7.
Iron oxide nanoparticles . . . . . . . . . . . .
3.8.
Quantum dots (QDs) . . . . . . . . . . . . . .
3.9.
Bacteriophage/virus particles . . . . . . . . . .
Nanotechnology based transducers . . . . . . . . . .
4.1.
Optical biosensors . . . . . . . . . . . . . . .
4.1.1.
Fluorescence-based detection . . . . .
4.1.2.
Refractive index detection . . . . . . .
4.2.
Electrochemical biosensors . . . . . . . . . . .
4.2.1.
Anodic stripping voltammetry (ASV) . .
4.2.2.
Amperometric sensors . . . . . . . .
4.2.3.
Potentiometric sensors . . . . . . . .
4.2.4.
Conductometric sensors . . . . . . . .
4.2.5.
Electrochemical impedance spectroscopy
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
. . .
(EIS)
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
165
165
165
165
165
166
166
166
166
167
167
168
168
168
169
169
169
170
170
170
171
171
172
172
172
173
173
Corresponding author at: Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Mumbai-400019, India. Tel.: + 91 22 3361 2217;
fax: + 91 22 3361 1020.
E-mail address: vbp_muict@yahoo.co.in (V.B. Patravale).
0168-3659/$ see front matter 2011 Elsevier B.V. All rights reserved.
doi:10.1016/j.jconrel.2011.11.033
4.3.
Microgravimetric (Piezoelectrical) . . . . . . . . . . . . . . . .
4.3.1.
Bulk wave (BW) or Quartz crystal microbalance (QCM) . .
4.3.2.
Surface acoustic wave (SAW) devices . . . . . . . . . .
4.3.3.
Magnetoelastic sensors . . . . . . . . . . . . . . . . .
4.4.
Magnetic biosensors . . . . . . . . . . . . . . . . . . . . . .
4.4.1.
NMR technique . . . . . . . . . . . . . . . . . . . .
4.4.2.
Magnetic eld sensors based on superconducting quantum
4.4.3.
Magnetoresistive-based biosensors . . . . . . . . . . .
5.
Future prospects . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1. General introduction
In today's changing scenarios, Prevention Is Better Than Cure the
paradigm has increasingly become hard-hitting truth of life [1,2]. The
capricious political situations have led to an increase in threat of potential biological weapons endangering the survival of mankind.
Broadly, these bio-chemical agents, Bacillus anthracis (anthrax), Variola major virus (small pox), Botulinum neurotoxins, Yersinia pestis,
Francisella tularensis, Burkholderia pseudomellei, Burkholderia mallei,
Rickettsia spp, Coxiella burnetti, Venezuelan equine encephalitis virus,
Marburg and Ebola viruses and inuenza viruses are considered to
have the great potential for mass causalities and civil disruption
[3,4]. Besides these, there are several emerging infectious diseases
with the potential for signicant public health consequences, including
malaria, HIV virus related complications, Dengue fever, West Nile fever,
and Rift Valley fever as well as tuberculosis [4]. As with biowarfare
agents, emerging infectious disease agents may be directly transmissible or vector borne. Further, infectious diseases prevalent in the developing world result in increased rates of morbidity and mortality.
While infectious diseases can initiate in a localized region, they can
spread rapidly at any moment due to the ease of traveling from one
part of the world to the next.
Because of the threat posed by both biowarfare agents and emerging or reemerging infectious disease agents, there is a need to develop
diagnostics for rapid identication of such agents in clinical setting in
order to treat the individuals at risk and to improve public health surveillance and epidemiology.
1.1. Traditional diagnostic techniques
1.1.1. Isolation, growth and microscopy
Traditionally, the presence of most pathogens such as bacteria,
fungi, protozoa and worms is determined microscopically, usually
after growth in a pure culture. These methods, although highly specific, have several limitations, to name a few; it is only useful for the
analysis of the samples having high pathogen load. It is a time consuming procedure (23 days for initial results, and up to 710 days
for conrmation) as growth pattern methods usually require the
growth of the pathogen in a particular medium followed by at least
a 24-h incubation period to yield results. It could result in false negative results especially in cases where some viable bacterial strains in
the environment can enter a dormancy state rendering them nonculturable (viable-but non-culturable (VBNC)) subsequently leading to
an underestimation of pathogen numbers or a failure to isolate and
identify a pathogen from a contaminated sample. These limitations
are even more signicant in the identication of viruses that due to
their small size (approx. 100 nm) cannot be studied using conventional optical microscopy and require the use of an electron microscope for their visualization. Moreover, prior to analysis, the culture
and growth of viruses in the laboratory necessitate use of extensive
protocols for their growth. Inspite of their disadvantages, conventional culture methods still represent a eld where progress is possible.
These methods are often combined together with other pathogen
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . . . . .
interference
. . . . . .
. . . . . .
. . . . . .
. . . . . .
. . .
. . .
. . .
. . .
. . .
. . .
device
. . .
. . .
. . .
. . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
. . . . .
(SQUID)
. . . . .
. . . . .
. . . . .
. . . . .
165
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
173
173
174
174
175
175
175
176
177
177
177
detection methods like an automated or semi-automated DNA, antibody, or biochemical-based method to yield more robust results [5].
1.1.2. Immunology-based methods
This technology relies on immunological based antibodies interaction for the detection of bacterial cells, spores, viruses and toxins alike.
Though the immunological-based detection is not much specic and
sensitive than nucleic acid-based detection, it is faster, more robust
and has the ability to detect not only contaminating organisms but
also their biotoxins that may not be expressed in the organism's genome. Unlike the earlier technique, this technology is being widely
used for the detection of the aforementioned infectious components.
Common examples of immunological techniques include the enzyme
immunoassay (EIA), enzyme linked immunosorbent assay (ELISA),
ow injection immuno-assay, enzyme-linked uorescent assay (ELFA),
bioluminescent enzyme immunoassay (BEIA), enzyme-linked immunomagnetic chemiluminescence (ELIMCL) immunochromatography (ICG)
strip test, immunomagnetic separation, immuno-precipitation assay,
agglutination test, radio-immunoassays (RIA), western blot test and
technically modied western blot include the line immunoassay (LIA)
and the recombinant immunoblot assay (RIBA) [6].
The prerequisite for this technique is detailed understanding of
the inuence of stress on antibody reactions as the physiological activities in cells are often altered in response to a stress. The technique
employs conventional and heavy chain antibodies, as well as polyclonal, monoclonal or recombinant antibodies. In comparison to
monoclonal antibodies, polyclonal antibodies can be raised quickly
and cost effectively however; polyclonal antibodies are limited both
in terms of their specicity and abundance. Hence, monoclonal antibodies are often more useful for specic detection of a wide variety
of microbes and their products because they provide an indenite
supply of single antibody with enhanced sensitivity, specicity, reproducibility and reliability [7].
Despite these salient features, monoclonal antibodies are an expensive alternative to polyclonal antibodies as they require a skilled
technician and specialized growth apparatus for tissue culturing.
Overcoming these issues, are recombinant antibodies since they can
be produced in reasonable quantities in short periods of time from
bacterial expression systems. Limitations of this technique are; inability to detect microorganisms in real-time at low pathogenic load,
low sensitivity of the assays and low afnity of the antibody to the
pathogen or other analyte being measured with potential interference from contaminants.
Likewise, immunology-based methods can be coupled with other
methods for pathogen detection, for instance, immunomagnetic separation on magnetic beads is coupled with matrix-assisted laser desorption ionization-time of ight mass spectrometry for detection of
Staphylococcal enterotoxin B [8], combination of immunomagnetic
separation with ow cytometry for detection of L. monocytogenes [9].
1.1.3. Polymerase chain reaction (PCR)
This method detects a single copy of a target DNA sequence, making
it promising because it detects the organism by amplifying the target
166
rather than the signal, and is therefore less prone to producing falsepositives. A target DNA can be amplied 1-million-fold in less than an
hour, with sensitivities in theory down to a single target pathogen.
Also it can be used to enhance the sensitivity of nucleic acid-based assays. PCR has distinct advantages over culture and other standard
methods for the detection of microbial pathogens and offers the advantages of specicity, sensitivity, rapidity, accuracy and capacity to detect
small amounts of target nucleic acid in a sample [10]. To date, PCR based
methods are used in the detection of wide range of pathogens like S. aureus, L. monocytogenes, Salmonella spp., Bacillus cereus, Escherichia coli
O157:H7, Yersinia enterocolitica, and Campylobacter jejuni. [6]. The different PCR based methods used to detect pathogens are real-time PCR,
multiplex PCR and reverse transcriptase PCR (RT-PCR). Compared to
other PCR based methods, multiplex PCR is very useful as it allows the
simultaneous detection of several DNA strands by introducing different
primers to amplify DNA regions coding for specic genes of each bacterial strain targeted. Multiplex PCR assay has been used for rapid and
simultaneous detection of E. coli O157:H7, Salmonella spp., S. aureus,
L. monocytogenes and Vibrio parahaemolyticus [11].
Recently, real-time RT-PCR has emerged as detection technique
which eliminates some purication and concentration steps that are
required for conventional RT-nested PCR detection. Unlike conventional PCR, real-time PCR based technologies are found to be rapid
due to their speed and high degree of sensitivity and specicity, enabling quicker results without too much manipulation. Limitations
of the PCR techniques includes; [7] false negative results due to target
cell lysis necessary for nucleic acid extraction, nucleic acid degradation and/or direct inhibition of PCR. Inability to distinguish between
viable and non-viable cells since DNA is always present whether the
cell is dead or alive. But this limitation can be overcome by using Reverse Transcriptase PCR (RT-PCR). Yaron and Matthews [12] developed an RT-PCR to detect only viable cells of E. coli O157:H7. Also
they suggested that, if RT-PCR is to be used for detection of live cells
in a sample without enrichment, then 10 7 colony-forming units
(cfu) of the target organism are required. Commercially, it can be expensive and complicated, requiring skilled workers to carry out the
tests. PCR is also being coupled with other techniques such as immunouorescent microscopy ELISA, immunomagnetic separation with
the reverse transcription multiplex TaqMan PCR system etc.
1.1.4. Miscellaneous techniques
Other reported analytical methods of pathogen detection include,
application of bacteriophages for detection and control of pathogens,
DNA oligonucleotide arrays, in which specic identication of pathogens was achieved without PCR amplication [6].
2. Potential of nanotechnology
Conventional molecular diagnostic techniques are widely used in
laboratories throughout the world to identify pathogenic agents
with high degree of sensitivity and reproducibility. However, most
of these techniques cannot be utilized in the eld (e.g. airports and
food distribution centers) or in developing countries where resources
are scarce, because they often require sophisticated, expensive instrumentation that needs to be used by trained personnel. Additionally,
the high cost and short shelve half-life of some reagents, such as enzymes and DNA primers, limit the application of most conventional
pathogen detection techniques in rural areas of developing nations.
167
Table 1
Summary of nanoparticles studied in the diagnosis of infections.
Pathogen
Nanomaterial
Recognition
Detection
method
Efciency/detection limit
Reference
E. coli
O157:H7
Qdots
Biotinylated
antibody
Antibody
Pathogen
Fluorescence
microscopy
Fluorometry
Visual
[57]
[58]
[59]
[60]
Titanium NPs
MycoD1
UVVis
Oligonucleotide spectroscopy
16S rRNA
UVVis
spectroscopy
Pathogen
MALDI-MS
Human
Dendrimer
Herpes Virus
Oligonucleotide Fluorescent
Inuenza virus
Human
Papilloma
Virus
HBV, HCV
antibodies
Qdots
Antibody
Au NPs/Ag staining
Protein A
Dynamic
Light
Scattering
Fluorescence
Protein chip
assay
[61]
[62]
[63]
[64]
[65]
Visual detection
[66, 67]
168
169
infects lung cells, it leaves part of its coat containing F and G proteins
on the cell's surface. QDs have been linked to antibodies keyed to
structures unique to the RSV coat. As a result, when QDs come in contact with either viral particles or infected cells they stick to their surface. Antibody-conjugated QDs rapidly and sensitively detect RSV and
estimate relative levels of surface protein expression [47]. A major development is the use of dual-color QDs or uorescence energy transfer nanobeads that can be simultaneously excited with a single light
source with improved sensitivity [48].
Thiolated CdSe-core QDs conjugated with wheat germ agglutinin
(WGA), a lectin that is commonly found in gram-positive bacteria,
have shown afnity for bacterial cells, for their ability to bind to sialic
acid and N-acetylglucosaminyl residues present on bacterial cell walls
[49]. QDs can also be bioconjugated with a substrate such as iron, which
is essential for the growth of pathogenic organisms inside a human host.
Pathogenic bacteria normally contain receptors for a human host's own
shuttle protein transferrin, and can harvest iron from transferrin. Using
this metabolism-specic approach, transferrin-conjugated QDs can be
transported through the membrane into metabolically active cells of
iron-deprived S. aureus and detected under uorescence excitation. In
contrast, no QD signal is observed in nonpathogenic bacteria [50]. QDs
have been further conjugated with specic antibodies to detect pathogenic microorganisms such as C. parvum and Giardia lambli [51].
3.9. Bacteriophage/virus particles
Though many methods are available, the low cost and ready production of large numbers of bacteriophage, along with their specicity for the target bacterial species make them ideal for detecting
bacteria. The advantage of detection with bacteriophage/virus particles is that they usually detect living bacteria thereby avoiding the
false positives that often arise from the use of approaches such as
PCR [52,53].
In phage amplication assays, bacterium is infected with the
phage which results in the release of many phage particles that can
be detected by a second (nonpathogenic), sensitive bacterial strain.
Phage based detection systems use engineered recombinant phages,
which upon infection of their hosts, these engineered phage deliver
reporter genes (such as luxAB genes from Vibrio harveyi) [54]. Replication of the viral genome results in many copies of the viral genome
being produced and subsequent expression of these genes ensures the
amplication of the initial phagebacterium interaction into a signal
that can be readily detected (bioluminescence in the case of luxAB) [55].
However, the excess phages, which have not infected the pathogenic bacteria being detected, the sensitivity decreases and hence it
requires that the excess phages to be destroyed.
Multifunctional virus particles conjugated to imaging agents
could serve as a probe for detecting biolm forming S. aureus [16].
Douglas group demonstrated that cowpea chlorotic mottle virus
(CCMV, 28 nm size) could be labeled with uorescent and Magnetic
Resonance Image (MRI) contrast agents. These virus particles were
loaded with imaging contrast agents (uorophore and MRI contrast
agent) and targeted to a biolm of S. aureus bacteria. The targeting
strategy was based on proteinligand interaction that consisted of streptavidin sandwiched between biotinylated CCMV and biotinylated antiSpA monoclonal antibody. The antibody was bound to the protein A
(SpA) that is expressed on the bacterial cell surface. The biotinylated
CCMV was tagged with uorescein, a uorescent dye and the targeting
was conrmed by ow cytometry analysis and epiuorescence microscopy [56].
By means of uorescence imaging, the depth of penetration of the
CCMV particles into S. aureus biolm was observed and the density of
binding was found to be exceptionally high. The CCMV particles were
assessed for its capacity to deliver MRI contrast agent Gadolinium
1,4,7,10-tetraazacyclododecane tetraacetic acid (Gd-DOTA) to S. aureus
cells. The concentration of Gd in the cell was analyzed by inductively
170
detected before and after an interaction taking place. It involves measurement of the uorescence quenching when the analyte is near the
surface of the uorophore-labeled optical waveguide. However, binding interactions between an activated signaling molecule and its target could be difcult to detect due to the difculty of seeing this
localized interaction over background uorescence. The use of QDs
as uorophores has overcome most of the drawbacks of using conventional dyes. Indirect biosensing which employs sandwich type approach, where a primary antibody having an afnity for the analyte of
interest is covalently bound to the surface of the ber and the sample
is introduced. Presence of the biomolecule of interest in the sample is
then conrmed using a secondary uorescent antibody, which uoresces when excited by the incident light from the evanescent wave.
Fluorescence biosensing, in which two uorophores are paired in
such a way that the emission wavelength of one overlaps with the excitation wavelength of the other and hence the excitation of one of
them will stimulate uorescence of the complementary pairing one
(if they reside within close proximity of about few angstroms from
each other). It has tremendous utility because the unique uorescence signal generated under these circumstances can be used to visualize and quantify the position and concentration of interacting
uorophores [13,14].
Edgar et al. reported a method that combined in vivo biotinylation
of engineered host-specic bacteriophage and conjugation of the
phage to streptavidin coated QDs. The method provides specic detection of E. coli with as few as 10 cfu/ml in experimental samples
[70].
4.1.1.1. Molecular beacons. They represent a recent technology that
use electronic energy transfer between a uorescent molecule and a
uorescent quencher. The ease of synthesis, unique functionality, molecular specicity and structural tolerance to various modications
has made them an important tool for biomolecular recognition [71].
They are single-stranded oligonucleotide hybridization probes generally 2560 nucleotides in length that form a stem-and-loop structure
and act like switches that are normally closed or off. The loop contains a probe sequence of DNA or RNA that is complementary to a target sequence. The stem structure holds the uorophore and the
quencher in close proximity, preventing the molecular beacons from
emitting uorescence. Binding to the target sequence induces conformational changes that open the loop and as a result the uorescence
is turned on. The resulting spatial separation of the uorophore from
the quencher leads to an enhancement in uorescence signal, because
the non-hybridized molecular beacon has minimal uorescence. The
increasing uorescence signal after each cycle is representative of
the increasing concentration of the amplied sequence (as shown in
Fig. 2).
The majority of surface immobilized probes incorporate a single
dye-based quencher molecule in signal transduction mechanisms.
Most widely used organic quencher, 4-((4-(dimethylamino) phenyl)
azo)benzoic acid (DABCYL), quenches at most 99.0% of the uorescence
of the dye placed in its proximity, but its quenching efciency decreases
for dyes emitting at longer wavelengths [72]. A rst time report for the
presence of Salmonella spp. in fruit and vegetable samples using an oligonucleotide probe that becomes uorescent upon hybridization to the
molecular beacon was evaluated in a real-time PCR assay. As few as
14 cfu per PCR reaction could be detected using the same quencher
(DABCYL) [73]. The studies with a hybrid material composed of a
1.4 nm diameter gold nanoparticle, an organic dye, and a 25nucleotide long ssDNA molecule showed that 1.4 nm diameter gold
nanoparticles can advantageously replace DABCYL as a quencher of
uorescence because they quench uorescence as much as 100 times
better and have higher quenching efciency for dyes emitting near
the infrared region [74].
In human disease diagnostics, molecular beacons immobilized
magnetic nanoparticles, or genomagnetic nanocapturers, have been
171
Table 2
Nanoparticles used in optical biosensors.
Nanoparticle (NP)
NP function
Signal
E. coli
amplication
Pathogen
LOD
Advantages
References
[81]
[82]
[83]
[84]
[85]
[86]
[87]
[88]
The electrochemical detection involves induction of the electrochemical property of the analyte by [89]; labeling or tagging one of
the recognition partners with an electroactive species. Commonly
used electrochemical labels could include ferrocene or In 2 + salts,
redox mediators (e.g. K3Fe[(CN)]63/4 ; methylene blue etc.) or enzymes (such as peroxidase, glucose oxidase, alkaline phosphatase or
catalase). Classically, electrochemical techniques suffer limitations
of poor sensitivity and false negative results. Further, there is also a
tendency that the labeling procedure may introduce undesired
changes in the host macromolecules or result in total loss of bioafnity or stability. Moreover, the labeling steps involved in the indirect
techniques can also impose additional time and cost constraints. With
the development of label-free, nanoparticle-modied electrochemical
systems, these limitations have been overcome [See Fig. 3] (Table 3).
Since the modication of the electrode surface by the deposition of
metal nanoparticles leads to the increase in the surface area which
enhances the interaction of biorecognition element with the electrode surface, subsequently resulting in the improved sensitivity [89].
Noble metals like gold have emerged as the most preferred material of construct for nanomodications of biosensors. It possesses inherent redox properties which impart remarkable sensitivity with
detection limits in the pM range [90]. For example, Wang et al. [91]
reported enzyme free approach in which streptavidin and ferrocenyl
hexathiol coated gold nanoparticles were used to monitor the DNA
hybridization by using the ferrocine groups as the reporter molecule
with a linear range for DNA between 7 and 150 pM.
Similarly, modied metal enhanced electrochemical detection approach was explored for detection of two base pair mismatches using
Microcystis as model. Using this methodology, a detection limit of
172
Fig. 3. Electrochemical detection of DNA-small molecule detection MED (A) preparation of silver monolayer on gold layer using upd, (B) immobilization of singlestranded probe DNA And (C) detection of target DNA due to complementary base
pairing.
of an electroactive species involved in the recognition process. The potential of the working electrode is maintained with respect to a reference electrode (usually Ag/AgCl), which is at equilibrium. The most
common working electrodes are noble metals, graphite, modied
forms of carbon or conducting polymers. The current generated is linearly related to the analyte concentration. They are more attractive because of their high sensitivity and wide linear range. However,
amperometric sensors can suffer from poor selectivity, especially
when applying potentials for oxygen/hydrogen peroxide detection,
but this can usually be overcome by using mediators (e.g. iodine, ferrocyanide, etc.) and perm-selective membranes [7,97].
Hasebe et al. [98] described a tyrosinase-based chemically amplied biosensor for the detection of E. coli. They employed a
tyrosinase-coupling electrode to detect polyphenolic compounds
produced microbially from salicyclic acid. The sensor was capable of
detecting 10 310 4 cells/ml but required a 3 h pre-enrichment period.
Brewster and Mazenko [99] also developed an immunoelectrical sensor,
which coupled with ltration capture, allowing rapid detection of E. coli
O157:H7. Cells were incubated with an enzyme-labeled antibody for
15 min and the antibodyantigen (bacteria) complex, captured on a cellulose acetate lter. The lter was brought in contact with the electrode
surface and 5 min after substrate addition, cells were detected by the
conversion of substrate (para-aminophenyl phosphate) to an electroactive product (para-aminophenol). The sensor could detect limit of
5000 cells/ml in an assay time of 25 min [99].
Immunomagnetic beads have also been used to increase the selectivity of amperometric biosensors. This technique requires that
Salmonella typhimurium is sandwiched between antibody coated
magnetic beads and an enzyme (alkaline phosphatase) labeled antibody. A magnet is then used to localize the beads onto the surface of
a disposable graphite ink electrode in a multiwell plate format. Cells
are detected by the oxidation of the electroactive enzyme product.
This offers a LOD of 8 10 3 cells/ml in buffer in a total analysis time
of 80 min [100].
4.2.3. Potentiometric sensors
Potentiometric sensors utilize the measurement of a potential at an
electrode in reference to another electrode. Mostly, it comprises of a
perm-selective outer layer and membrane or sensitive surface to a desired species (a bioactive material), usually an enzyme. The enzymecatalyzed reaction generates or consumes a species, which is detected
by an ion selective electrode. Usually a high impedance voltmeter is
used to measure the electrical potential difference or electromotive
force (EMF) between two electrodes at near zero current. Since potentiometry generates a logarithmic concentration response, the technique
allows the detection of extremely small concentration changes [99].
Table 3
Nanoparticles used in electrochemical biosensors.
Nanoparticle (NP)
NP function
Pathogen
LOD
Biosensing
system
Biosensing
system
Advantages
system
Magnetic NP-coated carbon nanotube nanocomposite Biosensing
E. coli
10 cfu/ml
system
Single-walled carbon nanotubes
Biosensing
S. infantis
100 cfu/ml
Assay time 1 h Label-free
system
system
Chitosan/Fe3O4 nanobiocomposite
Biosensing
HIV
50 pM
system
References
[114]
[115]
[116]
[117]
[118]
[119]
[120]
[121]
For enhanced sensitivity and label-free detection, silicon nanowires and carbon nanotubes have been used in fabrication of potentiometric biosensors [101,102]. Recently, light addressable potentiometric sensor (LAPS) has been developed for detection of microbial
contamination [97]. It consists of an n-type silicon semiconductorbased sensor and an insulating layer that is in contact with an aqueous solution where an immuno-reaction takes place. Changes in potential at the silicon-interface are detected by the difference in
charge distribution between the surface of the insulator and the sensor. A LAPS measures an alternating photocurrent generated by a light
source, such as a light emitting diode (LED), so that changes in potential can be transduced into voltage per time differentials. Using this
LAPS technology, molecular devices called Threshold Immunoassay
System has been marketed. In which, an immuno-complex is
formed in the solution phase between sample (antigen), a labeled antibody, biotinylated antibody and streptavidin, which is then captured onto solid phase biotinylated lter. Upon addition of substrate
the lter is brought in contact with the silicon semiconductor and
the enzyme generates a potentiometric signal [7]. This technique
has been exploited for the detection of Y. pestis and B. globigii spores
with a lower LOD of 10 cells or spores per sample [103]. They later
used the same technology to detect S. typhimurium to levels as low
as 119 cfu [104]. Similarly, the technique was used to assay for live
E. coli O157:H7 with a LOD of 2.5 10 4 cells/ml [105]. The US Department of Defense has introduced the Biological Integrated Detection
System for providing detection of airborne biological threats. One of
the instruments incorporated in this is the Biological Detector,
which works on the same principle as the Threshold Immunoassay
System. This system is capable of detecting eight agents simultaneously within 15 min. The LOD for B. subtilis is 3 10 3 cfu/ml [106].
This technique offers potential in the eld of nanodiagnostics although limits of detection still needs some improvement.
4.2.4. Conductometric sensors
The biorecognition event that changes the ionic concentration can
be monitored using conductometric sensors. Normally, they comprise
of two metal electrodes separated by a certain distance and an AC
voltage applied across the electrodes to cause a current ow. The
change in conductance/electrical impedance between the metal electrodes can be measured where the changes can be at an interface or in
the bulk region and can be used to indicate biomolecular reaction between DNA, proteins and antigen/antibody reaction or excretion of
cellular metabolic products.
Conductometric biosensors are characterized by their large sensitivity and represent a new pertinent class of analytical systems for diagnostic applications. Conductance techniques are attractive due to
their simplicity and ease of use since a specialized reference electrode
is not needed and they have been used to detect a wide variety of entities such as agents of biothreat, biochemicals, toxins and nucleic
acids. Conductometric sensors provide information on the ionic
strength in electrolytes and can provide selectivity if coupled with enzyme membranes [6,7,107]. Immobilized nanoparticles functionalized by the anti-coli antibody were shown to have an excellent
sensitivity with detection limit of 1 cfu/ml, coupled with a good specicity of binding [108]
4.2.5. Electrochemical impedance spectroscopy (EIS)
Electrochemical impedance spectroscopy is capable of directly
detecting the specic reaction between a receptor and its ligand. EIS
is widely used to characterize variations in the electronic properties
of bulk materials, and for investigating surface and interfacial processes on electrodes. It is a very efcient technique to measure biological binding events directly at the surface of an electrode. The
chemistry at the surface of the electrode determines the sensitivity
and the specicity of the biosensor. Compared to optical biosensors,
these biosensors offer the advantage of not being affected by the
173
turbidity of the sample, by the uorescence of certain molecules of biological interest, or by the quenching by certain substances [109,110].
Numerous EIS-based bioafnity sensors have been described for
proteins, DNADNA, AbAg or oligonucleotideDNA interactions.
These sensors have been designed by immobilizing bioafnity reagents (such as antigen, antibody, cells, DNA, enzyme layers, and
semiconductors/thin silica layer) at the surface of a solid electrode.
The binding of the molecular recognition partner is then veried
through the detection of either a shift in impedance, or change in capacitance or admittance at the bulk of the electrode interface. The EIS
was utilized for surface characterization of DNA immobilization and
hybridization. [111].
An immunosensor was developed using self-assembled monolayers
(SAM) at the surface of a gold electrode which allowed to detect whole
bacteria (E. coli) with a detection limit of 10 cfu/ml, a considerable improvement against the sensitivity of 107 cfu/ml obtained by surface
plasmon resonance optical detection [112]. The antibodies used in this
EIS biosensor were then coupled to magnetic nanoparticles. This coupling allowed the simultaneous purication of species of interest and
their concentration on the microelectrode by the simple use of a magnet, thus leading to functionalize the microelectrode to detect the corresponding antigen. Measurement of impedance (or admittance) was
used to measure the metabolic activity of microorganisms within
micro-uidic biochips. As bacterial cells are grown within microuidic channels and wells, the impedance changes in the medium can
be detected using electrodes placed appropriately within the channels.
These electrochemical immunosensors were further developed for viral
detection. A microelectrode based impedance immunosensor has been
developed for avian inuenza virus H5N1 detection [113].
4.3. Microgravimetric (Piezoelectrical)
This sensor was introduced in immunoassay format in 1972 by
Shons and associates who coated the quartz crystal surface with an
antigen for the detection of specic antibodies. These are masssensitive biosensors that are based on the detection of mechanical
acoustic waves. They are also referred as Acoustic wave based biosensors operating on the basis of an oscillating crystal that resonates
at a fundamental frequency. After the crystal has been coated with a
biological reagent (such as an antibody) and exposed to the particular
antigen a quantiable change occurs in the resonant frequency of the
crystal, which correlates to mass changes at the crystal surface [6].
In mass amplied piezoelectrical biosensors a sandwich assay format is used, where the sol modied secondary antibody is used. The
large mass of the bound sol particles greatly affects the vibrational
frequency of the quartz crystal and this is used as the basis for detection. The assay can be carried out in the competitive mode. The preferred diameter of sol particles is in the range of 5100 nm [68].
Other high-density particles (e.g. Au, Pt, CdS, TiO2, polymers) may
be also suitable [122,123]. In order to acquire an active surface for
use in a piezoelectric biosensor the surface must be stable chemically,
contain a high number of the actively immobilized biological elements and the coating surface should also be as thin as possible.
The most commonly used piezoelectric materials include quartz
(SiO2) and lithium niobate (LiTaO3) [7,124]. Acoustic wave biosensors
offer label-free, on-line analysis for antigenantibody interactions,
and also provide the option of several immunoassay formats, which
allow increased detection sensitivity and specicity. Other advantages include cost effectiveness combined with ease of use [97]. The
three main types of mass balance acoustic wave transducers are; [6]
4.3.1. Bulk wave (BW) or Quartz crystal microbalance (QCM)
The Bulk wave (BW) device or Quartz crystal microbalance (QCM)
is the oldest and simplest acoustic wave device in operation. This type
of acoustic wave transducers collectively includes bulk acoustic
wave (BAW), quartz crystal resonance sensors (QCRS) and
174
Fig. 4. Surface acoustic wave sensor, consisting of a cut crystal with two electrodes on
the same crystal face acting as both transmitter and receiver.
175
Table 4
Nanoparticles used in piezoelectrical (microgravimetric) biosensors.
Nanoparticle (NP)
NP function
Pathogen
LOD
Advantages
References
Oligonucleotide-functionalized AuNP
Biosensing system
[136]
Biosensing system
1:5500 dilution
ratio
84 ng/ml
[138]
[139]
Signal
Amplication
Mercapto Schistosoma japonicum antigen coated Signal
AuNP
Amplication
Human immunoglobulin G
(hIgG)
Schistosoma japonicum antibody 5 ng/ml
Fig. 5. Principle of DMR sensing assays using magnetic nanoparticles. a) Tagging cells
with magnetic nanoparticles imparts a magnetic moment that is proportional to the
number of nanoparticles bound. Prior to measurement of the magnetic moment as a
decrease in T2 relaxation time, the unbound nanoparticles are removed from the sample by washing. b) Magnetic relaxation switching assays involve assembly of magnetic
nanoparticle clusters using a target biomarker as a cross-linking bridge, or disassembly
of preformed clusters using an enzyme or competitive binding. Clustering magnetic
nanoparticles causes them to more efciently dephase the nuclear spins of neighboring
water molecules, shortening the transverse relaxation time (T2). Likewise, disassembly
of clusters increases T2 relaxation time.
[137]
176
Table 5
Nanoparticles used in magnetic biosensors.
Nanoparticle (NP)
NP function
Pathogen
Magnetic beads
Labeling and
quantication
Y. pestis
Biosensing
Magnetic NPs
Signal amplication
LOD
2.5 ng/ml in
buffer and
human blood
serum
V.
6.0 104 to
parahaemolyticus 5.8 106 cfu/ml
S. aureus
1 103 cfu/ml
E. coli
20 cfu/ml
remarkable interactions of electric currents and magnetic elds; observed when certain materials are cooled below a superconducting
transition temperature. At this temperature, the materials become superconductors and they lose all resistance to the ow of electricity. In
general, the superconducting ring in a SQUID is typically a toroid of
few millimeters in diameter, made up of a metal such as lead or niobium through which a line of magnetic ux is threaded continuously
without any disturbances [142]. The magnitude of the induced current is an exquisitely sensitive indicator of the ux density and magnetic eld intensity [146,147]. It is quantitised by interrupting the
superconducting ring with a weak-link, which is a narrow constriction in the superconductor or a point-contact junction. In SQUID, the
periodic variations are exploited to measure the current in the superconducting ring or the ambient magnetic eld. Typically, a radiofrequency circuit supplies a known bias eld that has been inductively coupled to the ring and also serves as the detector output. Changes
in the ring current alter the resonant frequency of the circuit; as a result, the output signal changes periodically as the eld varies [142].
The third component, i.e. the large antenna loop serves as a magnetic
antenna or dc search coil, effectively gathering ux over an area of
several square centimeters to improve sensitivity. The SQUID ring essentially serves as a very precise ammeter for measuring the current
in the pickup coil. But the sensitivity of SQUIDs is limited by the magnetic eld noise. The power consumption of several watts and bulkiness due to the need of liqueed coolant gasses makes the instrument
less useful in diagnostics and awaits for further modications.
A new technique has been introduced for rapid detection of biological targets by using super-paramagnetic nanoparticles and a microscope based on a high-transition temperature SQUID by Chamala et
al. [141]. In this technique, a mylar lm with bound targets is placed
on the microscope and a suspension of magnetic nanoparticles carrying
antibodies is added to the mixture in a well, and 1 s pulses of magnetic
eld are applied parallel to the SQUID. In the presence of this aligning
eld, the nanoparticles develop a net magnetization, which relaxes
when the eld is turned off. Unbound nanoparticles relax rapidly by
Brownian rotation and contribute no measurable signal. Nanoparticles
bound to the target are captured and undergo Neel relaxation, producing a slowly decaying magnetic ux, which is detected by the SQUID
[148]. The ability to distinguish between bound and unbound labels allows anyone to run homogeneous assays, which do not require separation and removal of unbound magnetic particles [68].
Grossman et al. [149] have employed this technique for detecting
magnetically labeled L. monocytogenes. They incorporated 50-nmdiameter superparamagnetic magnetite particles, coated with antibodies, to an aqueous sample containing L. monocytogenes and applied
a pulsed magnetic eld to align the magnetic dipole moments. The magnetic relaxation signal generated after the eld was turned off and measured using a high-transition temperature SQUID device. Since,
unbound particles randomize direction by brownian rotation, they are
Advantages
References
[157]
genomic bacterial DNA was used as a template for PCR using a 50-biotin
forward primer and a 50-uorescein reverse primer. The doublestranded-PCR product was then mixed with streptavidin-coated
super-paramagnetic particles. Finally, the particle complexes were captured by anti-uorescein antibodies and detected with the GMR platform [153]. Using this biosensor, 4250 pM amplicon concentrations
were detected in one-step format with total assay times of less than
3 min.
Another example is of immunomagnetic biosensor developed for
label-free detection of E. coli by Mujika et al. [154], they reported a
magneto-resistive immunosensor for the analysis of E. coli O157:H7
in food and clinical samples. This biosensor was capable of detecting
and quantifying small magnetic eld variations caused by the presence of super-paramagnetic beads bound to the antigens previously
immobilized on the sensor surface via an antibodyantigen reaction
[154]. In this same context, Maalouf and co-workers [155] described
an immunomagnetic biosensor for E. coli comprising streptavidinfunctionalized paramagnetic nanobeads attracted to a gold-electrode
surface via a magnetic eld. Biotinylated-anti E. coli antibodies were incubated with nanobeads and detection using impedimetric measurements yielding a working range of 10103 cfu/ml [155].
In recent years, the magnetic properties of some NPs have also
been used for separation or concentration of analytes in biosensing.
Recently, Liebana et al. [156] has reported detection of Salmonella in
skimmed-milk samples by applying immunomagnetic separation/
double-tagging PCR/electrochemical magneto-genosensing with an
LOD of 1 cfu/ml. In this methodology, Salmonella are captured from
milk and preconcentrated by immunomagnetic separation. The bacteria
attached to the magnetic beads are then lysed and the genomic DNA is
thus released. The amplication of the genetic material with a doubletagging set of primers is then performed to conrm the identity of the
bacteria by electrochemical magneto-genosensing [156] (Table 5).
5. Future prospects
Cell-based sensors are an emerging frontier in the area of nanodiagnostics. The use of cells as sensors is a very attractive way to devise sensitive biochemical detectors. With their highly selective and
sensitive receptors, channels and enzymes, intact cells are very attractive candidates for the development of biosensors. The main advantages of the cells as biosensors are that cells have built-in
natural selectivity to biologically active chemicals and they can react
to analytes in a physiologically relevant mode. The transductions of
the cell sensor signals maybe achieved by the measurement of transmembrane and cellular potentials, impedance changes, metabolic activity, analyte inducible emission of genetically engineered reporter
signals, and optically by means of uorescence or luminescence. Signicant challenges exist for long-term operation since the cells need
to be kept alive and healthy under various harsh operating conditions
and much work has been done towards this front, as this technology
has been extended to demonstrate automated portable cell based biosensors platform that have been eld tested [148,161]. Genetically
engineered B cells have been used as sensors, which emit light once
they have been infected by a toxin or a virus [162]. Microorganisms
have also been used as biosensors for the detection and monitoring
of environmental pollutants. Direct measurement of current through
ion channels in the cells has also been used to develop on-chip
patch clamp devices, which can potentially be very sensitive to
changes in the ambient conditions of the cells.
Furthermore, there is also an emergence of new concept Theranostics which very aptly combines the attributes of diagnosis and
therapy to combat infection [163]. Recently, silver nanoparticles a
noble metal known to exhibit strong toxic effects against prokaryotes
with low toxicity against human cells have been tested against a variety
of microbes [reviewed in [164,165]].
177
Kim et al. [167], Sondi and Salopek-Sondi [166] and Fabrega et al.
[168] investigated this activity of silver nanoparticles against E. coli
and other microorganisms In that study, electron microscopy
revealed pits in the cell walls, which is caused by the accumulation
of silver nanoparticles, resulting in alteration of membrane
morphology and increase in permeability, eventually leading to cell
death. Thus, the study very explicitly expounds the role of noble
nanomaterials in curbing the proliferation of bacteria. Hence, the
study provides a new dimension to the role of diagnostic
nanoparticles in diagnosis and thwarting the imminent threat of
bacterial infections [166-168].
Acknowledgement
This work has been supported by the UGC (University Grant Commission). The authors are thankful to Mr. Vinayak Datkhile, and Mr.
Sandeep Jadhav for technical assistance. The authors are also grateful
to Mr. Ramchandra Patale for his valuable suggestions.
References
[1] T. Barker, M. Lesnick, T. Mealey, R. Raimond, S. Walker, D. Rajeski, L. Timberlake,
Nanotechnology and the poor: opportunities and risksclosing the gaps within
and between sectors of society, Jan. 2005www.nanoandthepoor.org Last
accessed 5th Jan. 2010.
[2] Nanomedicine: Nanotechnology for Health, European Technology Platform:
Strategic Research Agenda for Nanomedicine, Nov. 2006, European Commission
[3] C.A. Mirkin, C.S. Thaxton, N.L. Rosi, Nanostructures in biodefense and molecular
diagnostics, Expert. Rev. Mol. Diagn. 4 (6) (2004) 749751.
[4] A.H. Peruski, L.F. Peruski, Immunological methods for detection and identication of infectious disease and biological warfare agents, Clin. Diagn. Lab. Immunol. 10 (4) (2003) 506513.
[5] C. Kaittanis, S.M. Santra, J.M. Perez, Emerging nanotechnology-based strategies
for the identication of microbial pathogenesis, Adv. Drug Deliv. Rev. 62
(2010) 408423.
[6] V. Velusamy, K. Arshak, O. Korostynska, K. Oliwa, C. Adley, An overview of foodborne
pathogen detection: In the perspective of biosensors, Biotechnol. Adv. 28 (2010)
232254.
[7] P. Leonard, S. Hearty, J. Brennan, L. Dunne, J. Quinn, T. Chakraborty, R. O'Kennedy,
Advances in biosensors for detection of pathogens in food and water, Enzyme
Microb. Technol. 32 (2003) 313.
[8] G. Schlosser, P. Kacer, M. Kuzma, Z. Szilagyi, A. Sorrentino, C. Manzo, Coupling
immunomagnetic separation on magnetic beads with matrix-assisted laser desorption ionization-time of ight mass spectrometry for detection of staphylococcal enterotoxin B, Appl. Environ. Microbiol. 73 (2007) 69456952.
[9] K. Hibi, A. Abe, E. Ohashi, K. Mitsubayashi, H. Ushio, T. Hayashi, Combination of
immunomagnetic separation with ow cytometry for detection of Listeria monocytogenes, Anal. Chim. Acta 573 (2006) 158163.
[10] B.C. Millar, J. Xu, J.E. Moore, Molecular diagnostics of medically important bacterial
infections, Mol. Biol. 9 (2007) 2140.
[11] J.S. Kim, G.G. Lee, J.S. Park, Y.H. Jung, H.S. Kwak, S.B. Kim, A novel multiplex PCR
assay for rapid and simultaneous detection of ve pathogenic bacteria: Escherichia
coli O157:H7, Salmonella, Staphylococcus aureus, Listeria monocytogenes, and Vibrio
parahaemolyticus, J. Food Prot. 70 (2007) 16561662.
[12] S. Yaron, K.R. Matthews, A reverse transcriptasepolymerase chain reaction
assay for detection of viable Escherichia coli O157:H7: investigation of specic
target genes, J. Appl. Microbiol. 92 (2002) 633640.
[13] M.N. Velasco-Garcia, Optical biosensors for probing at the cellular level: a review of recent progress and future prospects, Semin. Cell Dev. Biol. 20 (2009)
2733.
[14] T.V. Dinh, Nanosensing at the single cell level, Spectrochim. Acta Part B. 63
(2008) 95103.
[15] T.V. Dinh, P. Kasili, M. Wabuyele, Nanoprobes and nanobiosensors for monitoring
and imaging individual living cells, Nanomedicine 2 (2006) 2230.
[16] P. Tallury, A. Malhotra, L.M. Byrne, S.M. Santra, Nanobioimaging and sensing of
infectious diseases, Adv. Drug Deliv. Rev. 62 (2010) 424437.
[17] A.K. Singh, S.H. Harrison, J.S. Schoeniger, Gangliosides as receptors for biological
toxins: development of sensitive uoroimmunoassays using ganglioside-bearing
liposomes, Anal. Chem. 72 (2000) 60196024.
[18] S. Ahn-Yoon, T.R. DeCory, A.J. Baeumner, R.A. Durst, Gangliosideliposome immunoassay for the ultrasensitive detection of cholera toxin, Anal. Chem. 75
(2003) 22562261.
[19] A. Reichert, J.O. Nagy, W. Spevak, D. Charych, Polydiacetylene liposomes functionalized with sialic acid bind and colorimetrically detect inuenza virus, J. Am.
Chem. Soc. 117 (1995) 829830.
[20] M.R. West, T.W. Hanks, Polydiacetylene-based liposomes: an optical tongue
for bacteria detection and identication, J. Chem. Educ. 86 (2009) 373.
[21] C.P. Poole, F.J. Owens, Chapter 5, Carbon Nanostructures: Introduction to Nanotechnology, A John Wiley & sons, inc., Pub, 2003, pp. 103132.
178
[22] L. Gu, T. Elkin, X. Jiang, H. Li, Y. Lin, L. Qu, T.R.J. Tzeng, R. Joseph, Y.P. Sun, Singlewalled carbon nanotubes displaying multivalent ligands for capturing pathogens,
Chem. Commun. (Camb) 21 (2005) 874876.
[23] P.G. Luo, F.J. Stutzenberger, Nanotechnology in the detection & control of microorganisms, Adv. Appl. Microbiol. 63 (2008) 145181.
[24] G.A. Zelada-Guilln, S.V. Bhosale, J. Riu, F.X. Rius, Real-time potentiometric
detection of bacteria in complex samples, Anal. Chem. 82 (22) (2010)
92549260.
[25] C. Garca-Aljaro, L.N. Cella, D.J. Shirale, M. Park, F.J. Muoz, M.V. Yates, A. Mulchandani,
Carbon nanotubes-based chemiresistive biosensors for detection of microorganisms,
Biosens. Bioelectron. 26 (4) (2010) 14371441.
[26] W.D. Janga, K.M.K. Selimb, C.H. Lee, I.K. Kang, Bioinspired application of dendrimers: from bio-mimicry to biomedical applications, Prog. Polym. Sci. 34 (2009)
123.
[27] M. Ozkan, Quantum dots and other nanoparticles: what can they offer to drug
discovery? Drug Discov. Today 9 (24) (2004) 10651071.
[28] J. Wang, M. Jiang, T.W. Nilsen, R.C. Getts, Dendritic nucleic acid probes for DNA
biosensors, J. Am. Chem. Soc. 120 (1998) 82818282.
[29] D. Pissuwan, C.H. Cortie, S.M. Valenzuela, M.B. Cortie, Functionalised gold nanoparticles for controlling pathogenic bacteria, Trends Biotechnol. 4 (28) (2010)
207213.
[30] S.H. Huang, Gold nanoparticle based immunochromatographic assay for the detection of Staphylococcus aureus, Sens. Actuators B 127 (2007) 335340.
[31] L. Wang, Q.-S. Wei, C. Wu, Z.Y. Hu, J. Ji, The Escherichia coli O157:H7 DNA detection on a gold nanoparticle-enhanced piezoelectrical biosensor, Chin. Sci. Bull.
53 (2008) 11571184.
[32] R.L. Philips, O.R. Miranda, C.C. You, V.M. Rotello, U.H.F. Bunz, Rapid and efcient
identication of bacteria using gold nanoparticle-poly(para-phenyleneethynylene) constructs, Angew. Chem. Int. Ed. Engl. 47 (2008) 25902594.
[33] R.T. Ahuja, D. Kumar, Recent progress in the development of nano-structured
conducting polymers/nanocomposites for sensor applications, Sens. Actuators
B 136 (2009) 275286.
[34] Q. Sheng, J. Wang, J. Zheng, Z. Xub, H. Zhang, Ultrasensitive electrical biosensing
of syphilis DNA using target-guided formation of polyaniline based on enzymecatalyzed polymerization, Biosens. Bioelectron. 9 (25) (2010) 20712077.
[35] C. Garca-Aljaroa, M.A. Bangar, E. Baldrich, F.J. Munoz, A. Mulchandan, Conducting
polymer nanowire-based chemiresistive biosensor for the detection of bacterial
spores, Biosens. Bioelectron. 25 (10) (2010) 23092312.
[36] E.B. Setterington, E.C. Alocilja, Rapid electrochemical detection of polyanilinelabeled Escherichia coli O157:H7 Biosens, Bioelectron 26 (5) (2011) 22082214.
[37] S. Tang, M. Moayeri, Z. Chen, H. Harma, J. Zhao, H. Hu, R.H. Purcell, S.H. Leppla,
I.K. Hewlett, Detection of anthrax toxin by an ultrasensitive immunoassay
using Europium nanoparticles, Clin. Vaccine Immunol. 16 (2009) 408413.
[38] D. Polpanich, P. Tangboriboonrat, A. Elaissari, R. Udomsangpetch, Detection of
malaria infection via latex agglutination assay, Anal. Chem. 79 (2007)
46904695.
[39] C. Corot, P. Robert, J.M. Idee, M. Port, Recent advances in iron oxide nanocrystal
technology for medical imaging, Adv. Drug Deliv. Rev. 58 (2006) 14711504.
[40] K.K. Jain, Chapter 3, Nanomolecular diagnostics, The Handbook of Nanomedicine,
Human Press, Totowa, NJ, 2008, pp. 7476.
[41] C. Kaittanis, S.A. Naser, J.M. Perez, One-step, Nanoparticle-mediated bacterial
detection with magnetic relaxation, Nano Lett. 7 (2) (2007) 380383.
[42] H. Gu, P.-L. Ho, K.W.T. Tsang, L. Wang, B. Xu, Using biofunctional magnetic nanoparticles to capture vancomycin resistant enterococci and other gram positive
bacteria at ultra low concentrations, J. Am. Chem. Soc. 125 (51) (2003)
1570215703.
[43] N.P. Pera, A. Kouki, S. Haataja, H.M. Branderhorst, R.M.J. Liskamp, G.M. Visser, J. Finne,
R.J. Pieters, Detection of pathogenic Streptococcus suis bacteria using magnetic glycoparticles, Org. Biomol. Chem. 8 (2010) 24252429.
[44] H.M.E. Azzazy, M.M.H. Mansour, S.C. Kazmierczak, From diagnostics to therapy:
prospects of quantum dots, Clin. Biochem. 40 (2007) 917927.
[45] H.M.E. Azzay, M.M.H. Mansour, S.C. Kazmierczak, Nanodiagnostics: a new frontier
for clinical laboratory medicine, Clin. Chem. 52 (7) (2006) 12381246.
[46] K.K. Jain, Applications of nanobiotechnology in clinical diagnostics, Clin. Chem.
53 (11) (2007) 20022009.
[47] E.L. Bentzen, F. House, T.J. Utley, J.E. Crowe, D.W. Wright, Progression of respiratory
syncytial virus infection monitored by uorescent quantum dot probes, Nano Lett. 5
(2005) 591595.
[48] A. Agarwal, R.A. Tripp, L.J. Anderson, S. Nie, Real time detection of virus particles
and virus protein expression with two color nanoparticle probes, J. Virol. 79
(2005) 86258628.
[49] J.A. Kloepfer, R.E. Mielke, M.S. Wong, K.H. Nealson, G. Stuvky, J.L. Nadeau, Quantum
dots as strain- and metabolism specic microbiological labels, Appl. Environ.
Microbiol. 69 (2003) 42054213.
[50] B. Modun, J. Morrissey, P. Williams, The staphylococcus transferrin receptor: a
glycolytic enzyme with novel functions, Trends Microbiol. 8 (2000) 231237.
[51] L. Zhu, S. Ang, W.T. Liu, Quantum dots as a novel immunouorescent detection
system for Cryptosporium parvum and Giardia lamblia, Appl. Environ. Microbiol.
70 (2004) 597598.
[52] M. Manchester, P. Singh, Virus-based nanoparticles (VNPs): platform technologies
for diagnostic imaging, Adv. Drug Deliv. Rev. 58 (2006) 15051522.
[53] N.k. Petty, T.J. Evans, P.C. Fineran, G.P.C. Salmond, Biotechnological exploitation
of bacteriophage research, Trends Biotechnol. 1 (25) (2006) 715.
[54] M. Oda, M. Morita, H. Unno, Y. Tanji, Rapid detection of Escherichia coli O157:H7
by using green uorescent protein labeled PP01 bacteriophage, Appl. Environ.
Microbiol. 70 (2004) 527534.
[55] M.J. Loessner, C.E. Rees, G.S. Stewart, S. Scherer, Construction of luciferase reporter of bacteriophage A511: luxAB for rapid and sensitive detection of viable
listaria cells, Appl. Environ. Microbiol. 62 (1996) 11331140.
[56] P.A. Suci, D.L. Berglund, L. Liepold, S. Brumeld, B. Pitts, W. Davison, L. Oltrogge,
K.O. Hoyt, S. Codd, P.S. Stewart, M. Young, T. Douglas, High-density targeting of a
viral multifunctional nanoplatform to a pathogenic biolm-forming bacterium,
Chem. Biol. 14 (2007) 387398.
[57] M.A. Hahn, J.S. Tabb, T.D. Krauss, Detection of single bacterial pathogens with
semiconductor quantum dots, Anal. Chem. 77 (2005) 48614869.
[58] X.L. Su, Y. Li, Quantum dot biolabeling coupled with immunomagnetic separation for detection of Escherichia coli O157: H7, Anal. Chem. 76 (2004)
48064810.
[59] J.A. Ho, S.C. Zheng, W.H. Tseng, Y.J. Lin, C.H. Chen, Liposome-based immunostrip
for the rapid detection of Salmonella, Anal. Bioanal. Chem. 391 (2008) 479485.
[60] E. Liandris, M. Gazouli, M. Andreadou, M. Comor, N. Abazovic, L.A. Sechi, J. Ikonomopoulos, Direct detection of unamplied DNA from pathogenic mycobacteria
using DNA-derivatized gold nanoparticles, J. Microbiol. Methods 78 (2009)
260264.
[61] P. Gill, M. Ghalami, A. Ghaemi, N. Mosavari, H. Abdul-Tehrani, M. Sadeghizadeh,
Nanodiagnostic method for colorimetric detection of Mycobacterium tuberculosis
16S rRNA, Nanobiotechnol 4 (2008) 2835.
[62] J. Gopal, J.L. Narayana, H.F. Wu, TiO2 nanoparticle assisted mass spectrometry as
biosensor of Staphylococcus aureus, key pathogen in nosocomial infections from
air, skin surface and human nasal passage, Biosens. Bioelectron. 27 (1) (2011)
201206.
[63] H.M. Striebel, E. Birch-Hirschfeld, R. Egerer, Z. Foldes-Papp, G.P. Tilz, A. Stelzner,
Enhancing sensitivity of human herpes virus diagnosis with DNA microarrays
using dendrimers, Exp. Mol. Pathol. 77 (2) (2004) 8997.
[64] J.D. Driskell, C.A. Jones, S.M. Tompkins, R.A. Tripp, One-step assay for detecting
inuenza virus using dynamic light scattering and gold nanoparticles, Analyst
136 (15) (2011) 30833090.
[65] J.M. Klostranec, Q. Xiang, G.A. Farcas, J.A. Lee, A. Rhee, E.I. Lafferty, S.D. Perrault,
K.C. Kain, W.C.W. Chan, Convergence of quantum dot barcodes with microuidics and signal processing for multiplexed high-throughput infectious disease
diagnostics, Nano Lett. 7 (2007) 28122818.
[66] Y.F. Wang, D.W. Pang, Z.L. Zhang, H.Z. Zheng, J.P. Cao, J.T. Shen, Visual gene diagnosis
of HBV and HCV based on nanoparticle probe amplication and silver staining enhancement, J. Med. Virol. 70 (2003) 205211.
[67] L. Duan, Y. Wang, S.S.C. Li, Z. Wan, J. Zhai, Rapid and simultaneous detection of
human hepatitis B virus and hepatitis C virus antibodies based on a protein chip
assay using nano-gold immunological amplication and silver staining method,
BMC. Infect. Dis. 5 (53) (2005).
[68] N. Sanvicens, C. Pastells, N. Pascual, M.P. Marco, Nanoparticle-based biosensors
for detection of pathogenic bacteria, Trends Anal. Chem. 28 (2009) 12431251.
[69] C. Jianrong, M. Yuqing, H. Nongyue, W. Xiaohua, L. Sijiao, Nanotechnology and
biosensors, Biotechnol. Adv. 22 (2004) 505518.
[70] R. Edgar, M. McKinstry, J. Hwang, A.B. Oppenheim, R.A. Fekete, G. Giulian, C.
Merril, K. Nagashima, S. Adhya, High sensitivity bacterial detection using
biotin-tagged phage and quantum-dot nanocomplexes, Proc. Natl. Acad. Sci. U.
S. A. 13 (103) (2006) 48414845.
[71] W. Tan, K. Wang, T.J. Drake, Molecular beacons, Curr. Opin. Chem. Biol. 8 (2004)
547553.
[72] S. Tyagi, F.R. Kramer, Molecular beacons: probes that uoresce upon hybridization, Nat. Biotechnol. 14 (1996) 303308.
[73] S.H. Liming, A. Bhagwat, Application of a molecular beaconreal-time PCR technology to detect Salmonella species contaminating fruits and vegetables, Int. J.
Food Microbiol. 95 (2004) 177187.
[74] B. Dubertret, M. Calame, A.J. Libchaber, Single-mismatch detection using goldquenched uorescent oligonucleotides, Nat. Biotechnol. 19 (4) (2001) 365370.
[75] X. Zhao, R. Tapec-Dytioco, K. Wang, W. Tan, Collection of trace amounts of
DNA/mRNA molecules using genomagnetic nanocapturers, Anal. Chem. 75
(2003) 34763483.
[76] J. Li, X. Fang, S. Schuster, W. Tan, Molecular beacons: a novel approach to detect
proteinDNA interactions, Angew. Chem. Int. Ed. 6 (39) (2000) 10491052.
[77] A. Leung, P.M. Shankar, R. Mutharasan, A review of ber optic biosensors, Sens.
Actuators B 125 (2007) 688703.
[78] A.J. Haes, R.P. Van Duyne, Nanoscale optical biosensors based on localized surface plasmon resonance spectroscopy, Proc. SPIE 5221 (2003) 4758.
[79] M.C. Daniel, D. Astruc, Gold nanoparticles: assembly, supramolecular chemistry,
quantum size-related properties, and applications toward biology, catalysis, and
nanotechnology, Chem. Rev. 104 (2004) 293346.
[80] W.P. McConnell, J.P. Novak, L.C. Brousseau III, R.R. Fuierer, R.C. Tenent, D.L. Feldheim, Electronic and optical properties of chemically modied metal nanoparticles and molecularly bridged nanoparticle arrays, J. Phys. Chem. B 104 (2000)
89258930.
[81] M.A. Hahn, P.C. Keng, T.D. Krauss, Flow cytometric analysis to detect pathogens
in bacterial cell mixtures using semiconductor quantum dots, Anal. Chem. 3 (80)
(2008).
[82] Z. Wang, H. Xu, J. Wu, J. Ye, Z. Yang, Sensitive detection of Salmonella with uorescent bioconjugated nanoparticles probe, Food Chem. 125 (2011) 779784.
[83] R.A. Tripp, R. Alvarez, B. Anderson, L. Jones, C. Weeks, W. Chen, Bioconjugated
nanoparticle detection of respiratory syncytial virus infection, Int. J. Nanomedicine 2 (1) (2007) 117124.
[84] X. Wang, X. Lou, Y. Wang, Q. Guo, Z. Fang, X. Zhong, H. Mao, Q. Jin, L. Wu, H.
Zhao, J. Zhao, QDs-DNA nanosensor for the detection of hepatitis B virus DNA
and the single-base mutants, Biosens. Bioelectron. 25 (8) (2010) 19341940.
179
[116] S.K. Mwilu, A.O. Aluoch, S. Miller, P. Wong, O.A. Sadik, Identication and quantitation of Bacillus globigii using metal enhanced electrochemical detection and
capillary biosensor, Anal. Chem. 81 (18) (2009) 75617570.
[117] P.R. Marques, A. Lermo, S. Campoy, H. Yamanaka, J. Barbe, S. Alegret, M.I. Pividori, Double-tagging polymerase chain reaction with a thiolated primer and
electrochemical genosensing based on gold nanocomposite sensor for food safety, Anal. Chem. 81 (2009) 13321339.
[118] S. Viswanathan, L.C. Wu, M.R. Huang, J.A. Ho, Electrochemical immunosensor for
cholera toxin using liposomes and poly(3,4-ethylenedioxythiophene)-coated
carbon nanotubes, Anal. Chem. 78 (2006) 11151121.
[119] Y. Cheng, Y. Liu, J. Huang, K. Li, Y. Xian, W. Zhang, L. Jin, Amperometric tyrosinase
biosensor based on Fe3O4 nanoparticles-coated carbon nanotubes nanocomposite for rapid detection of coliforms, Electrochim. Acta 54 (9) (2009) 25882594.
[120] R.A. Villamizar, A. Maroto, F.X. Rius, I. Inza, M.J. Figueras, Fast detection of Salmonella
infantis with carbon nanotube eld effect transistors, Biosens. Bioelectron. 24 (2008)
279283.
[121] L.D. Tran, B.H. Nguyen, N.V. Hieu, H.V. Tran, H.L. Nguyen, P.X. Nguyen, Electrochemical detection of short HIV sequences on chitosan/Fe3O4 nanoparticle
based screen printed electrodes, Mater. Sci. Eng., C 31 (2011) 477485.
[122] X. Su, F.T. Chew, S.F.Y. Li, Design and application of piezoelectric quartz crystalbased immunoassay, Anal. Sci. 16 (2) (2000) 107114.
[123] T. Liu, J. Tang, L. Jiang, The enhancement effect of gold nanoparticles as a surface
modier on DNA sensor sensitivity, Biochem. Biophys. Res. Commun. 313
(2004) 37.
[124] P.D. Skottrup, M. Nicolaisen, A.F. Justesen, Towards on-site pathogen detection
using antibody-based sensors, Biosens. Bioelectron. 24 (2008) 339348.
[125] M.A. Cooper, V.T. Singleton, A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of
biomolecular interactions, J. Mol. Recognit. 20 (2007) 154184.
[126] H. Xia, F. Wang, Q. Huang, J. Huang, M. Chen, J. Wang, C. Yao, Q. Chen, G. Cai, W.
Fu, Detection of Staphylococcus epidermidis by a quartz crystal microbalance
nucleic acid biosensor array using Au nanoparticle signal amplication, Sensors
8 (2008) 64536470.
[127] X. Mao, L. Yang, X.-L. Su, Y. Li, A nanoparticle amplication based quartz crystal
microbalance DNA sensor for detection of Escherichia coli O157:H7, Biosens.
Bioelectron. 21 (2006) 11781185.
[128] E.V. Olsen, I.B. Sorokulova, V.A. Petrenko, I.H. Chen, J.M. Barbaree, V.J. Vodyanoy,
Afnity-selected lamentous bacteriophage as a probe for acoustic wave biodetectors of Salmonella typhimurium, Biosens. Bioelectron. 21 (8) (2006)
14341442.
[129] V. Nanduri, I.B. Sorokulova, A.M. Samoylov, A.L. Simonian, V.A. Petrenko, V.
Vodyanoy, Phage as a molecular recognition element in biosensors immobilized
by physical adsorption, Biosens. Bioelectron. 22 (2007) 986992.
[130] R.L. Bunde, E.J. Jarvi, J.J. Rosentreter, Piezoelectric quartz crystal biosensors,
Talanta 46 (1998) 12231236.
[131] F.F. Chou, H.W. Chang, T.L. Li, J.S. Shih, Piezoelectric crystal/surface acoustic
wave biosensors based on fullerene C60 and enzymes/antibodies/proteins, J.
Iran. Chem. Soc. 5 (1) (2008) 115.
[132] C.M. Ruan, K.F. Zeng, O.K. Varghese, C.A. Grimes, A staphylococcal enterotoxin B
magnetoelastic immunosensor, Biosens. Bioelectron. 20 (2004) 585591.
[133] K.G. Ong, K. Zeng, X. Yang, K. Shankar, C. Ruan, C.A. Grimes, Quantication of
multiple bioagents with wireless, remote-query magnetoelastic microsensors,
IEEE Sens. J. 6 (2006).
[134] S. Huang, S.-Q. Li, H. Yang, M. Johnson, J. Wan, I. Chen, Optimization of phage-based
magnetoelastic biosensor performance, Sens. Transducers 3 (2008) 8796.
[135] F. Xie, H. Yang, S. Li, W. Shen, J. Wan, M.L. Johnson, Amorphous magnetoelastic
sensors for the detection of biological agents, Intermetallics 17 (2009) 270273.
[136] S.H. Chen, Y.C. Chuang, Y.C. Lu, H.C. Lin, Y.L. Yang, C.S. Lin, A method of layer-bylayer gold nanoparticle hybridization in a quartz crystal microbalance DNA sensing
system used to detect dengue virus, Nanotechnol 20 (2009) 215501215511.
[137] H. Wang, C.X. Lei, J.S. Li, Z.Y. Wu, G.L. Shen, R.Q. Yu, A piezoelectric immunoagglutination assay for Toxoplasma gondii antibodies using gold nanoparticles, Biosens.
Bioelectron. 19 (2004) 701709.
[138] X.-Y. Jin, X.-F. Jin, Y.-J. Ding, J.-H. Jiang, G.-L. Shen, R.-Q. Yu, A piezoelectric
immunosensor based on agglutination reaction with amplication of silica
nanoparticles, Chin. J. Chem. 26 (12) (2008) 21912196.
[139] W. Zhaoyang, W. Jian, S. Wang, G. Shen, R. Yu, An amplied mass piezoelectric
immunosensor for Schistosoma japonicum, Biosens. Bioelectron. 22 (2006)
207212.
[140] J.M. Perez, F.J. Simeone, Y. Saeki, L. Josephson, R. Weissleder, Viral-induced selfassembly of magnetic nanoparticles allows the detection of viral particles in biological
media, J. Am. Chem. Soc. 125 (2003) 1019210193.
[141] Y.R. Chemla, H.L. Grossman, Y. Poon, R. McDermott, R. Stevens, M.D. Alpert,
Ultrasensitive magnetic biosensors for homogeneous immunoassay, Proc. Natl.
Acad. Sci. U. S. A. 97 (2000) 1426814272.
[142] J. Lenz, A.S. Edelstein, Magnetic sensors and their applications, IEEE Sens. J. 6 (3)
(2006) 631649.
[143] H. Lee, T.J. Yoon, R. Weissleder, Ultrasensitive detection of bacteria using coreshell nanoparticles and an NMR-lter system, Angew. Chem. Int. Ed. 48 (2009)
56575660.
[144] V. Pizzella, S.D. Penna, C.D. Gratta, G.L. Romani, SQUID systems for biomagnetic
imaging, Supercond. Sci. Technol. 14 (2001) R79R114.
[145] R. Cantor, SQUID's and emerging applications, Supercond. Cryoelectron 13
(2001) 1622.
[146] B.S. Deaver, W.M. Fairbank, Experimental evidence for quantized ux in superconducting cyclinders, Phys. Rev. Lett. 7 (1961) 4346.
180
[159]
[160]
[161]
[162]
[163]
[164]
[165]
[166]
[167]
[168]
100A, Food Microbiol: General II, Ann. Meeting and Food Expo - Anaheim, California,
2002.
H. Lee, E. Sun, D. Ham, R. Weissleder, Chip-NMR biosensor for detection and molecular analysis of cells, Nat. Med. 14 (2008) 869874.
Y. Cheng, Y. Liu, J. Huang, K. Li, W. Zhang, Y. Xian, L. Jin, Combining biofunctional
magnetic nanoparticles and ATP bioluminescence for rapid detection of Escherichia
coli, Talanta 77 (2009) 13321336.
J.J. Pancrazio, J.P. Whelan, D.A. Borkholder, W. Ma, D.A. Stenger, Development
and application of cell based biosensors, Ann. Rev. Biomed. Eng. 27 (6) (1999)
697711.
T.H. Rider, M.S. Petrovick, F.E. Nargi, J.D. Harper, E.D. Schwoebel, R.H. Mathews, D.J.
Blanchard, L.T. Bortolin, A.M. Young, J. Chen, M.A. Hollis, A B-cell-based sensor for
rapid identication of pathogens, Science 301 (5630) (2003) 213215.
F.J. Picard, M.G. Bergeron, Rapid molecular theranostics in infectious diseases,
Drug Discov. Today 21 (7) (Nov. 2002).
N. Duran, P.D. Marcato, R. De Conti, O.L. Alves, F.T.M. Costa, M. Brocchi, Potential
use of silver nanoparticles on pathogenic bacteria, their toxicity and possible
mechanisms of action, J. Braz. Chem. Soc. 6 (21) (2010) 949959.
J.R. Morones, J.L. Elechiguerra, A. Camacho, K. Holt, J.B. Kouri, J.T. Ramirez, M.J.
Yacaman, The bactericidal effect of silver nanoparticles, Nanotechnology 16
(2005) 2346.
I. Sondi, B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case
study on E. coli as a model for Gram-negative bacteria, J. Colloid Interface Sci.
275 (2004) 177182.
J.S. Kim, E. Kuk, K.N. Yu, J.-H. Kim, S.J. Park, H.J. Lee, S.H. Kim, Y.K. Park, Y.H. Park,
C.-Y. Hwang, Y.-K. Kim, Y.-S. Lee, D.H. Jeong, M.-H. Cho, Antimicrobial effects of
silver nanoparticles, Nanomedicine 3 (2007) 95101.
J. Fabrega, C.J. Renshaw, R. Jamie, Lead interactions of silver nanoparticles with
Pseudomonas putida biolms, Environ. Sci. Technol. 43 (23) (2009) 90049009.